Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer. ESR1 ...

Dr Robert DeBernardo explains how new immunotherapies are reshaping care and how their earlier availability might have affected one patient's course.

Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

In this video, Azka Ali, MD, medical oncologist at the Cleveland Clinic Taussig Cancer Institute, highlights interesting ...

Cancer is transported from one organ to another by invisible bubbles. Understanding these microscopic messengers could change ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...

Early menopause is more than just an end to menstruation before the age of 45—it could be a genetic signpost for heightened breast cancer risks. Kirtly Jones, MD, talks to endocrinologist Corinne Welt ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Appendiceal cancer is a rare cancer without standardized screening guidelines, risk factors or tumor classifications - a situation that often results in late diagnosis and poor prognosis. Up to 1 of ...

This group of local executive leaders works together to create a culture of health in their own workplaces, helping employees ...